Literature DB >> 6700099

Serological response to rubella revaccination.

M K Serdula, S B Halstead, N H Wiebenga, K L Herrmann.   

Abstract

To document the serological response, 21 seronegative rubella vaccinees (hemagglutination inhibition [HI] titer less than 10) were revaccinated with RA 27/3 rubella vaccine. All demonstrated an anamnestic response. Although RA 27/3 vaccine was an effective booster, antibody boost was not maintained in some persons. Of 15 persons tested, 24 to 27 months after revaccination, six had a significant HI antibody drop (fourfold or greater); only one had lost all detectable HI antibody. Although all 21 study participants were initially HI seronegative by rubella HI testing, 16 (76.2%) possessed neutralization and/or enzyme-linked immunosorbent assay antibodies before revaccination. As more persons with vaccine-induced immunity join the adult population pool, more sensitive test methods may be needed to assess serological status accurately.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6700099

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  8 in total

1.  Identifying risk factors for rubella susceptibility in a population at risk in the United States.

Authors:  M Carolina Danovaro-Holliday; Ely R Gordon; Charles Woernle; Gary H Higginbotham; Randa H Judy; Joseph P Icenogle; Susan E Reef
Journal:  Am J Public Health       Date:  2003-02       Impact factor: 9.308

2.  Preventive health examinations.

Authors:  M Russell; H Bryant
Journal:  Can Fam Physician       Date:  1988-12       Impact factor: 3.275

Review 3.  Rubella vaccines: past, present and future.

Authors:  J M Best
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

4.  Evidence against increasing rubella seronegativity among adolescent girls.

Authors:  P A Stehr-Green; S L Cochi; S R Preblud; W A Orenstein
Journal:  Am J Public Health       Date:  1990-01       Impact factor: 9.308

5.  Increasing rubella seronegativity despite a compulsory school law.

Authors:  T R Schum; D B Nelson; M A Duma; G V Sedmak
Journal:  Am J Public Health       Date:  1990-01       Impact factor: 9.308

6.  Detection of rubella virus-specific immunoglobulin G (IgG), IgM, and IgA antibodies by immunoblot assays.

Authors:  T Zhang; C A Mauracher; L A Mitchell; A J Tingle
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

7.  Characterization of rubella virus-specific antibody responses by using a new synthetic peptide-based enzyme-linked immunosorbent assay.

Authors:  L A Mitchell; T Zhang; M Ho; D Décarie; A J Tingle; M Zrein; M Lacroix
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

8.  How to determine protective immunity in the post-vaccine era.

Authors:  Carmen L Charlton; Florence Y Lai; Douglas C Dover
Journal:  Hum Vaccin Immunother       Date:  2016-04-02       Impact factor: 3.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.